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Rana nigrovittataMuch attention has been paid on amphibian peptides for their wide-ranging pharmacological properties,
clinical potential, and gene-encoded origin. More than 300 antimicrobial peptides (AMPs) from amphibians
have been studied. Peptidomics and genomics analysis combined with functional test including
microorganism killing, histamine-releasing, and mast cell degranulation was used to investigate
antimicrobial peptide diversity. Thirty-four novel AMPs from skin secretions of Rana nigrovittata were
identiﬁed in current work, and they belong to 9 families, including 6 novel families. Other three families are
classiﬁed into rugosin, gaegurin, and temporin family of amphibian AMP, respectively. These AMPs share
highly conserved preproregions including signal peptides and spacer acidic peptides, while greatly
diversiﬁed on mature peptides structures. In this work, peptidomics combined with genomics analysis
was conﬁrmed to be an effective way to identify amphibian AMPs, especially novel families. Some AMPs
reported here will provide leading molecules for designing novel antimicrobial agents.
© 2009 Elsevier Inc. All rights reserved.Introduction
Amphibian skins act as the ﬁrst line to defend against noxious
aggression by microorganisms, parasites, predators, and physical
harm. Amphibians, being the ﬁrst group of organisms forming a
connecting link between land and water, are forced to adopt and
survive in a variety of conditions laden with pathogens and
predators. Amphibian skins play key roles in their everyday survival
and their ability to exploit a wide range of habitats and ecological
conditions [1]. Amphibians are endowed with an excellent chemical
defense system composed of pharmacological and antimicrobial
gene-encoded peptides [2,3]. These peptides have pharmacological
effects including cardiotoxic, myotoxic, neurotoxic, and antimicrobial
activities [1]. All the properties clearly adversely affect potential
predators or pathogens.
A remarkably diverse array of antimicrobial peptides (AMPs),
10–50 residues in length, have been found in skins of anuran
amphibians, particularly those belonging to the families of Pipidae,College of Life Sciences, Hebei
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ll rights reserved.Hylidae, Hyperoliidae, and Ranidae [4-10]. They are released onto
the outer layer of the skin to provide an effective and fast-acting
defense against harmful microorganisms [4,5]. Most of amphibian
AMPs have a common N-terminal preproregion, which is highly
conserved both intra- and inter-speciﬁcally, followed by a
markedly different C-terminal domain that corresponds to mature
AMPs. They have been suggested to originate from a common
ancestor [4,5,7].
In order to investigate the diversity of amphibian antimicrobial
peptides,methods of peptidomics combinedwith genomicswere used
to identify novel AMPs from the skin of the frog, Rana nigrovittata.
Results
Puriﬁcation of AMPs from skin secretions of the frog R. nigrovittata
The skin secretions of R. nigrovittata were fractionated into six
fractions by Sephadex G-50 gel ﬁltration as our previous report [11].
Fractions IV and V containing antimicrobial activities were subjected
to further puriﬁcation by C8 and C18 RP-HPLC, respectively. As
indicated in Fig. 1A, more than 30 peaks were eluted from fraction
IV by C8 RP-HPLC, and peaks A1–A6 were found to contain
antimicrobial activities. Fig. 1B showed that more than 40 peaks
were eluted from fraction V by C18 RP-HPLC, and peaks B1–B10 were
found to contain antimicrobial activities. These fractions were further
Fig. 1. RP-HPLC puriﬁcation of antimicrobial peptides from R. nigrovittata skin secretions. Six fractions were eluted from Sephadex G-50 gel ﬁltration as our previous report [11]. The
fraction IV (A) and V (B) were subjected to further puriﬁcation by C8 and C18 RP-HPLC columns equilibrated with 0.1% (v/v) triﬂuoroacetic acid/water, respectively. The elutions
were performed with the indicated gradient of acetonitrile with 0.1% (v/v) triﬂuoroacetic acid/acetonitrile at a ﬂow rate of 0.7 ml/min, and fractions were tested for antimicrobial
activity. The puriﬁed antimicrobial peptides were indicated in A (A1–A6) and B (B1–B10).
67Y. Ma et al. / Genomics 95 (2010) 66–71analyzed by MALDI-TOF mass spectrometry and subjected to amino
acid sequencing.
Structure analysis
Peaks A1–A6 and B1–B10 were analyzed by MALDI-TOF mass
spectrometry and amino acid sequencing. Peptides from the peaks A3,
B6, and B7 have not been determined in current experiments.
Thirteen puriﬁed AMPs with determined amino acid sequences
were listed in Table 1. They belong to nine peptide families including
nigroain-B to nigroain-E, nigroain-I, nigroain-K, gaegurin-RN, rugo-
sin-RN, and temporin-RN.
These AMP families all contain one disulﬁde bridge except
nigroain-C, nigroain-I, and temporin. Interestingly, there are three
cysteines in the nigroain-B family while most of amphibian
antimicrobial peptides contain two cysteines. After digestion by
trypsin, nigroain-B3 was analyzed by MALDI-TOF mass spectrometry
(data not shown). The result showed that two cysteines positioned at
the C-terminus of nigroain-B3 formed a disulﬁde bridge and one
cysteine at the N-terminus was free. The synthetic nigroain-B3 had
the same bioactivity and mass spectrometry with the puriﬁed
nigroain from the skin secretions, which further conﬁrmed the
structure of nigroain-B3. Most of the observed masses of these
AMPs matched well with their theoretical masses deduced from
primary structures, with an error less than 0.5 U (Table 1, Fig. S1).
Only themass error (+1.47) of rugosin-RN3 is larger than 0.5, and the
reason is not clear yet. Another interesting antimicrobial family is
nigroain-C, containing a single cysteine. Sequence and mass spec-
trometry analysis (mass error of −0.49) indicated that the single
cysteine in nigroain-C2 was free.
cDNA screening of AMPs
One hundred and sixty-eight cDNA clones (Genbank accession nos.
EU136401–EU136568) encoding AMP homologues were screenedfrom the skin cDNA library of R. nigrovittata. These cDNA clones
encode 34 different peptides including those puriﬁed from the skin
secretions as described above, and belong to 9 peptide families (Table
1). BLAST search indicated that six families (nigroain-B to -E, nigroain-
I, and nigroain-K) are novel peptide families because no similar
sequences are found. The other three families designated as gaegurin-
RN, rugosin-RN, and temporin-RN are similar to families of gaegurin
[12], rugosin [13], and temporin [14], where RN is the abbreviation of
R. nigrovittata.
Compared with other members, some of the peptides from
families like nigroain-B4, -B5, -K1, and gaegurin-RN6 obviously are
size and structure different. Extreme diversity of skin AMPs could be
observed in a single individual. In the case of gaegurin-RN6, the stop
codon mutation results in reading frame extension, creating a
peptide of 47 amino acids, compared with the original length of 24
residues. In contrast to gaegaurin-RN6, nigroain-B4, -B5, and -K1
have a length of 12, 8, and 22 amino acid residues, respectively,
shortened from the original length (19 and 31 amino acid residues),
due to the creation of a premature termination codon. In addition, in
these cases, these truncated peptides have lost the carboxyterminal
conserved disulﬁde-bridged heptapeptide segments (CKLTGNC,
CRVLGRC, CKVAGGC). A single point mutation in nigroain-D
destroyed the disulﬁde bridge by changing the second cysteine into
an arginine while maintaining the original length of the peptide.
The diversity of AMPs in R. nigrovittata also resides in disulﬁde
motif in their sequences. Nigroain-B and -K, gaegurin-RN, and
rugosin-RN have a seven-residue loop disulﬁded by two cysteines
positioned at the C-terminus as found in most of amphibian skin AMP
families. Nigroain-D has a 13-residue loop disulﬁded by two cysteines
positioned at the N-terminus, while nigroain-E has the same loop in
the middle of its sequence. To our knowledge, disulﬁde bridges
composed of 11–13 residues only have been described in the frog of
Odorrana grahami [7].
In addition, nigroain-D and -E are interesting templates or leading
structures to design peptide antibiotics. The whole sequences of
Table 1
Antimicrobial peptides from the skin of the frog, R. nigrovittata.
Peptides Sequences Elution position in Fig. 1 OM TM MD
Nigroain-B1 CVISAGWNHKIRCKLTGNC
Nigroain-B2 CVISAGWDHKVRCKLTGNC
Nigroain-B3 CKI-ALPYH-MRCRVLGRC B5 2017.48 2017.54 −0.06
Nigroain-B4 CVISAGWNHKIR
Nigroain-B5 CKIALPYT
Nigroain-C1 FKTWKRPPFQTSCSGIIKE
Nigroain-C2 FKTWKRPPFQTSCWGIIKE B9 2352.29 2352.78 −0.49
Nigroain-D1 CVHWQTNPARTSCIGP
Nigroain-D2 CVHWQTNPARTSRIGP
Nigroain-D3 CVHWQTNTARTSCIGP B2 1772.49 1772.00 +0.49
Nigroain-E1 DCTRWIIGINGRICRD B3 1889.91 1889.20 +0.71
Nigroain-E2 GCTQWINNIHGRICVRN
Nigroain-I SFLSKFKDIALDVPRMRARVY B8 2513.30 2513.00 +0.30
Nigroain-K1 SLWETIKNAGKGFIQNILDKIR
Nigroain-K2 SLWETIKNAGKGFILNILDKIRCKVAGGCKT A4 3376.58 3376.05 +0.53
Gaegurin-RN1 FIGPVLKIAAGILPTAICKIFKKC A1 2542.94 2543.27 −0.33
Gaegurin-RN2 FIGPVLKIATSILPTAICKIFKKC
Gaegurin-RN3 FLGPIIKIATGILPTAICKILKKC
Gaegurin-RN4 FVGPVLKIAAGILPTAICKIYKKC B10 2545.14 2545.24 −0.10
Gaegurin-RN5 FLGPIIKIATGILPTAICKFLKKC A2 2587.55 2587.32 +0.23
Gaegurin-RN6 FLGPIIKIATGILPTAICKILKKMLKLWKWKSS
DVEYHLAKCTSDVL
Gaegurin-RN7 FLGPIIKIATGILPTAICKILKNVETLEMEII
Rugosin-RN1 SIRDKIKTIAIDLAKSAGTGVLKTLICKLDKSC
Rugosin-RN2 SIRDKIKTIAIDLAKGAGTGVLKTLICKLDKSC
Rugosin-RN3 SIRDKIKTIAIDLAKSAGMGILKTLICKLDKSC A6 3547.83 3546.36 +1.47
Rugosin-RN4 SIRDKIKTIAIDLAKSAGTGVLKTSICKLDKSC
Rugosin-RN5 SIRDKIKTIAIDLAKSAGTGVLKTLICKLNKSC A5 3501.08 3501.26 −0.18
Rugosin-RN6 SFLSKFKDIALDVAKNAGKGVLTTLACKIDGSC
Rugosin-RN7 RFLSKFKDIALDVAKNAGKGVLTTLACKIDGSC
Rugosin-RN8 SFLSKFKDIALDVAKNAGKGVLTTLARKIDGSC
Rugosin-RN9 SFLSKIKDIALDVAKNAGKGVLTTLACKIDGSC
Temporin-RN1 FLPLVLGALSGILPKIL-NH2 B1 1762.95 1763.27 −0.32
Temporin-RN2 FFPLLFGALSSLLPKLF-NH2
Temporin-RN3 FFPLLFGALSSHLPKLF-NH2 B4 1933.45 1933.35 +0.10
OM, observed mass; TM, theoretical mass; MD, mass difference.
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disulﬁde bonds.
We have puriﬁed and sequenced only 13 of the 34 peptides
represented by the cDNAs we have characterized (Table 1). Other 21
peptides are just deduced from the cDNAs. However, to our
knowledge, mRNA sequences isolated from frog skin universally are
found to be translated into peptides. We suggest, but have not yet
proven, that expressed mRNAs for which no peptide has as yet been
isolated are actually translated into stable peptides.
Peptide precursor sequences
The precursors encoding nine families of AMP from R.
nigrovittata were aligned in Fig. 2. These AMPs are from the
precursors that have a common N-terminal preproregion, which is
highly conserved, followed by a markedly different C-terminal
domain that corresponds to the mature AMPs. They also share the
conserved enzymatic processing sites (-Lys-Lys-, Lys-Arg-, or -Arg-
Arg-) to release the mature peptides. The remarkable similarity of
preproregions of precursors that give rise to very different AMPs
suggests that the corresponding genes form a multigene family
originating from a common ancestor. Many gene diversiﬁcations
forming multigene family have been found. For example, 180 cDNA
sequences of four-loop conotoxins have been reported from two
species of the venomous gastropod Conus [15]. It was suggested
that gene duplication and diversifying selection result in the
formation of functionally variable conotoxins that are linked to
ecological diversiﬁcation and evolutionary success of this genus.
Their skeletons of the gene products are not changed although
they have experienced extensive diversiﬁcation. All of the Conustoxins encoded by these diversiﬁed genes contain a “-C————
C————CC—C——C-” cysteine “backbone” [15]. In contrast to the
Conus toxins, the “backbones” in translated products of the
diversiﬁed genes reported in this paper are extensively changed.
Most of AMP families have lost the loop disulﬁded by cysteines. A
similar type of structural diversity is seen in the vertebrate
cathelicidin family precursor, where the C-terminal can include
linear proline/arginine rich segments, linear alpha-helical seg-
ments, and segments with disulﬁde bonds, sometimes even from a
single species (i.e., the pig) [16].
Antimicrobial activities
The diversiﬁcation on primary structures of the AMPs from R.
nigrovittata skin may underlie their diverse activities. Peptides that
were representative of different families in the current population of
skin peptides exhibited diverse activities (Table 2). However, peptides
belonging to the same family also exhibited diverse activities.
Nigroain-C3 and temporin-RN3 exhibit antimicrobial activities
against all of the tested microbes including Gram-positive and
Gram-negative bacteria and fungi. Nigroain-D3 and -E1 appear to
target narrow antimicrobial spectrum, with low potency. Gaegurin-
RN, rugosin-RN, and temporin-RN showed comparably antimicrobial
abilities. The functional signiﬁcance of structure diversiﬁcation among
these different families of an AMP has been compared as mentioned
above. Considering that the sequence diversiﬁcation not only
occurred in different families but also occurred within the same
ones, we checked the functional signiﬁcance of structure diversiﬁca-
tion that occurred within families of nigroain-K, gaegurin-RN,
rugosin-RN, and temporin-RN. As listed in Table 2, different AMP
Fig. 2. The sequence alignment of the precursors of antimicrobial peptides. The predicted signal peptides are italic; the mature peptides are underlined; Odorranain-A1 is from
Li et al. [7].
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speciﬁcity and potential.
Hemolytic activity
Some AMPs were found to exert hemolytic activities [6,7]. Rabbit
red blood cells were used to check for hemolytic capability in our
experiments. Most AMPs exhibited weak hemolytic activity at the
concentration of 100 μg/ml (Table 3). In contrast, nigroain-K2,
gaegurin-RN1, temporin-RN1, and temporin-RN3 had strong hemo-
lytic activity against rabbit red cells. Nigroain-K2 and temporin-RN1
could destroy 85–95% red cells even at the concentration of 50 μg/
ml. Compared with nigroain-K2, nigroain-K1 lost the C-terminal
disulﬁde bridge, and had a much weaker hemolytic activity. The
current result implies that the C-terminal disulﬁde bridge may
contribute to the hemolytic activity.
Mast cell degranulation assays (MCD)
Mast cells are secretory cells central to speciﬁc and innate
immunity, allergy, and inﬂammation. Mast cells are present in most
body tissues, but are particularly numerous in connective tissue,
such as the dermis (innermost layer) of skin. In an allergic response,
an allergen stimulates the release of antibodies, which attach
themselves to mast cells. Following subsequent allergen exposure,
the mast cells release substances such as histamine (a chemical
responsible for allergic symptoms) into the tissue [17-22]. As listed
in Table 4, most of AMPs (50 μg/ml) from the skin of R. nigrovittata
could induce mast cell degranulation, with the control of 0.1% (v/v)
Triton X-100, suggesting that these AMPs can regulate or mediate
antimicrobial response by stimulating mast cell degranulation.
Among them, the families of gaegurin-RN and temporin-RN showed
much stronger ability to induce mast cell degranulation than other
families. Half of the tested peptide could induce histamine release
(Table 4). Nigroain-B1 had weak ability to induce mast cell
degranulation, but showed a strong histamine-releasing activity.
On the contrary, nigroain-E1 could induce mast cell degranulationTable 2
Antimicrobial activity of antimicrobial peptides from skin of R. nigrovittata.
Microorganisms MICa (μg/ml)
B1 C2 D3 E1 K1 K2
S. aureus ATCC25923 50.00 27.50 ND 18.75 9.38 11.2
S. aureus ATCC43300 50.00 55.00 ND ND ND 9.38
B. subtilis ND 110.00 55.00 ND 21.88 9.38
C. albicans ATCC2002 ND 13.75 110.00 75.00 32.74 15.0
E. coli ML-35P ND 110.00 ND ND 37.50 ND
P. aeruginosa PA01 25.00 55.00 ND ND ND ND
P. aeruginosa ATCC27853 25.00 55.00 ND ND ND ND
ND, no detectable antimicrobial activity in a dose up to 100 μg/ml; B-E, nigroain-B to -E; K
a Minimal peptide concentration required for total inhibition of cell growth in liquid me
b Means have detectable antimicrobial activity by the method of ﬁlter paper but not totabut inhibited histamine release. These results together suggest that
mast cell degranulation and histamine release induced by amphibian
AMPs are not consistent although histamine is a kind of chemical
mediator released by mast cell.
Discussion
The growing problem of resistance to conventional antibiotics
has stimulated the need for developing new human therapeutics.
The gene-encoded AMPs play an important role in innate immunity
against noxious microorganisms [1]. Since they cause much less
drug resistance of microbes than conventional antibiotics, AMPs
nowadays attract considerable attention for the development of
new antibiotics [1]. Amphibian skin is a multifunctional organ
acting as defence, respiration, and water regulation although it
seems susceptible. Amphibian skins are easy to be harmed by
biological or non-biological attacks such as microorganism infection.
Among vertebrates, skins of amphibian are exposed to more
dangers of microorganism injury than others. Amphibian skins are
potential reservoir to explore antimicrobial agents. Recently, we
identiﬁed 107 AMPs belonging to 30 different families from O.
grahami skin, 24 out of which are of novel families. They have
similar precursors and theoretically originate from the common
ancestor [7]. So many AMPs from a single species suggest that the
possible amount of amphibian AMPs might be far more than those
already known. Traditional biochemical methods, such as peptide
puriﬁcation and sequencing, encounter difﬁculties in identifying
peptides expressed in trace. It is necessary to develop new strategy
to identify defensive agents from amphibian skins and to avoid
killing many amphibians. Precursors of Ranidae amphibian antimi-
crobial peptides have been proved to share conserved signal peptide
sequence. Based on conserved signal peptide sequence in precursors
of AMPs, peptidomics combined with cDNA trapping is an effective
way to investigate novel amphibian AMPs [4,5,7]. The current
results further conﬁrmed the efﬁciency. Nine different families
AMPs including six novel families were isolated from the skin
secretions of R. nigrovittata. Another three families are belonging toGN1 GN4 GN5 RN1 RN3 RN5 TN1 TN3
5 2.34 1.17 3.75 4.69 16.51 15.00 4.69 3.75
9.38 9.38 62.50 ND ND 12.50 ND 7.50
4.69 2.34 4.69 9.38 18.75 18.75 9.38 7.50
0 4.69 2.34 4.69 5.63 15.00 18.75 8.26 3.75
18.75 ND 37.50 25.00 25.00 25.00 ND 15.00
ND ND ND ND ND ND 4.69 3.75
ND ND ND N100b N100b ND 4.69 3.75
, nigroain-K; GN, gaegurin-RN; RN, rugosin RN; TN, temporin-RN.
dium.
l inhibition of cell growth in liquid medium in a dose up to 100 μg/ml.
Table 3
Red cell hemolysis activity of antimicrobial peptides from skin of R. nigrovittata.
Samples Hemolysis (%)a Samples Hemolysis (%)a
B1 ND GN4 18.64±0.25
C2 ND GN5 16.16±3.22
D3 ND RN1 6.69±1.51
E1 7.62±1.60 RN3 ND
K1 22.49±4.80 RN5 ND
K2b 85.52±3.26 TN1b 95.7±4.12
GN1 46.13±1.49 TN3 87.2±3.67
The percentages represent values±SD (standard deviations) of three independent
experiments performed in duplicate. ND, no detectable hemolysis in a dose up to
100 μg/ml; B-E, nigroain-B to -E; K, nigroain-K; GN, gaegurin-RN; RN, rugosin RN; TN,
temporin-RN. Triton X-100 (0.1%, v/v) was used as 100% control.
a The sample concentration was 100 μg/ml.
b The sample concentration is 50 μg/ml.
Table 4
Mast cell degranulation (MCD) and histamine-releasing (HR) activity of antimicrobial
peptides from skin of R. nigrovittata.
Samples MCD (%)a HR (%)a Samples MCD (%)a HR (%)a
B1 15.04±2.29 32.52±7.63 GN4 45.99±0.36 38.68±2.46
C2 7.31±1.63 ND GN5 56.12±7.98 54.71±1.02
D3 ND ND RN1 14.33±4.86 ND
E1 8.87±1.63 −8.42±0.16 RN3 4.43±0.35 ND
K1 10.94±1.49 ND RN5 ND ND
K2 29.78±4.24 24.03±0.60 TN1 77.57±4.32 25.67±2.76
GN1 63.86±10.17 24.84±3.48 TN3 80.43±0.97 24.52±6.98
The percentages represent values±SD (standard deviations) of three independent
experiments performed in duplicate. ND, no detectable activity in a dose up to 50 μg/
ml; B-E, nigroain-B to -E; K, nigroain-K; GN, gaegurin-RN; RN, rugosin RN; TN,
temporin-RN. Triton X-100 (0.1%, v/v) was used as 100% control.
a The percent of activity in a dose up to 50 μg/ml.
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respectively.
Some AMPs found in current work have unique structures, such as
nigroain-B with three cysteines, nigroain-C with single cysteine, and
nigroain-D and -E of which the whole sequences are nearly fallen into
the circles connected by disulﬁde bonds. Such special structure might
grant the peptides increased stability and strengthened resistance
against protease. Therefore, these AMPs provide novel templates or
leading structures to design antimicrobial agents.
Materials and methods
Collection of frog skin secretions
Adult specimens of R. nigrovittata of both sexes (n=30; weight
range 30–40 g) were collected in Yunnan Province of China and skin
secretions were collected as follows. Frogs were put into a cylinder
container, a piece of absorbent cotton immersed with anhydrous
ether was put on the top of the container, and the container was
covered with a lid and permeated with volatilized anhydrous ether.
After 1–2 min, frog skin surface was seen to exude copious secretions.
Skin secretions were collected by washing the dorsal region of each
frog with 0.1 M NaCl solution (containing protease inhibitor cocktail).
The collected solutions (500 ml of total volume) were quickly
centrifuged at 5000 × g for 20 min and the supernatants were
lyophilized.
Peptide puriﬁcation
Lyophilized skin secretion sample of R. nigrovittata (1.2 g, total
OD280 nm of 300) was dissolved in 10 ml 0.1 M phosphate buffer, pH
6.0, containing 5 mM EDTA. The sample was applied to a Sephadex
G-50 (Superﬁne, Amersham Biosciences, 2.6×100 cm) gel ﬁltration
column equilibrated with 0.1 M phosphate buffer, pH 6.0. Elution
was performed with the same buffer, collecting fractions of 3.0 ml.
The absorbance of the elute was monitored at 280 nm. The
antimicrobial activity of fractions was determined as indicated
below. The fractions containing antimicrobial activities were pooled,
lyophilized, and re-suspended in 0.1 M phosphate buffer, pH 6.0, and
puriﬁed further by C18 or C8 reverse-phase high-performance liquid
chromatography (RP-HPLC, Hypersil BDS C18 or C8, 30×0.46 cm) as
illustrated in Fig. 1.
Structural analysis
Complete peptide sequencing was undertaken by Edman degra-
dation on an Applied Biosystems pulsed liquid-phase sequencer,
model 491. The fractions with antimicrobial activity from RP-
HPLC were analyzed by MALDI (Kratos Analytical). Mass ﬁnger-
prints (MFPs) were obtained using a matrix-assisted laser desorptionionization time-of-ﬂight mass spectrometer (MALDI-TOF-MS)
AXIMA CFR (Kratos Analytical) in positive ion and linear mode.
The speciﬁc parameters were as follows: the ion acceleration
voltage was 20 kV, the accumulating time of single scanning was
50 s, polypeptide mass standard (Kratos Analytical) serving as
external standard. The accuracy of mass determinations was within
0.1%.
SMART cDNA synthesis
Total RNAwas extracted using TRIzol (Life Technologies Ltd.) from
the skin of a single frog. cDNA was synthesized by SMART™
techniques by using a SMART™ PCR cDNA synthesis kit (Clontech,
Palo Alto, CA). The ﬁrst strand was synthesized by using cDNA 3′
SMART CDS Primer II A, 5′-AAGCAGTGGTATCAACGCAGAGTACT (30)
N-1N-3′ (N=A, C, G, or T; N-1=A, G, or C), and SMART II An
oligonucleotide, 5′-AAGCAGTGGTATCAACGCAGAGTACGCGGG-3′. The
second strand was ampliﬁed using Advantage polymerase by 5′ PCR
primer II A, 5′-AAGCAGTGGTATCAACGCAGAGT-3′.
cDNA cloning
AMPs from Ranidae amphibians have been intensively studied.
The conserved preproregion in Ranidae AMP precursor comprises a
hydrophobic signal peptide of 22 residues followed by a 16–25
residue acidic propiece which terminates by a typical prohormone
processing signal Lys-Arg. Most of the signal peptides of Ranidae
AMP precursor have a sequence of MF(T/P)(L/M)KKS(L/M/F/P)LL
(L/V)L [7]. The cDNA synthesized by SMART™ techniques was used
as template for PCR to screen the cDNAs encoding AMPs. Two
oligonucleotide primers, RS1 (5′-CCAAA(G/C)ATGTTCACC(T/A)TGAAGAAA(T/
C)-3′), in the sense direction, a speciﬁc primer designed according
to the signal peptide sequences of AMPs from ranid frogs and primer
II A as mentioned in “SMART cDNA synthesis” in the antisense
direction were used in PCR reactions. The DNA polymerase was
Advantage polymerase from Clontech (Palo Alto, CA) The PCR
conditions were as follows: 2 min at 94 °C, followed by 30 cycles
of 10 s at 92 °C, 30 s at 50 °C, 40 s at 72 °C. Finally, the PCR products
were cloned into pGEM®-T Easy vector (Promega, Madison, WI).
DNA sequencing was performed on an Applied Biosystems DNA
sequencer, model ABI PRISM 377.
Antimicrobial testing
Microorganisms including Gram-positive bacterium Staphylo-
coccus aureus (ATCC2592), S. aureus (ATCC43300, methicillin
resistance), Gram-negative bacteria Escherichia coli (ML-35P)
(penicillin resistance), Bacillus dysenteriae, Pseudomonas aeruginosa
PA01, P. aeruginosa (ATCC27853), and fungus Candida albicans
71Y. Ma et al. / Genomics 95 (2010) 66–71(ATCC2002) were obtained from Kunming Medical College and
were ﬁrst grown in LB (Luria–Bertani) broth or yeast extract–
peptone–dextrose broth as our previous report [7]. MICs (minimal
inhibitory concentration) of AMP against tested microorganisms
were determined as previous reports [7]. The MIC was deﬁned as
the lowest concentration of test peptides inhibiting microorganism
growth.
Hemolytic assays
Hemolytic assays were undertaken using rabbit red blood cells in
liquid medium as reported [23]. Serial dilutions of the peptide were
used, and after incubation at 37 °C for 30 min, the cells were
centrifuged and the absorbance in the supernatant was measured at
540 nm. Maximum hemolysis was determined by adding 1% Triton X-
100 to a sample of cells.
Mast cell degranulation assays
Mast cell degranulation was determined by measuring the
release of β-D-glucosaminidase from lysed mast cells. Wistar rats
were killed by cervical dislocation and mast cells were obtained by
peritoneal washing of adult Wistar rats with Tyrode's solution
(137 mM NaCl, 2.7 mM KCl, 1.36 mM CaCl2, 0.49 mM MgCl2,
0.36 mM NaH2PO4, 11.9 mM NaH2CO3, and 5.04 mM D-glucose).
Ten microliter samples were added to 90 μl mast cells suspensions
and incubated at 37 °C for 15 min. After centrifugation, 50 μl
supernatants were added to 50 μl of the substrate (3 mg of ρ-
nitrophenyl-N-acetyl-β-D-glucosaminidine dissolved in 10 ml of
200 mM sodium acetate, pH 4.5 solution) for β-D-glucosaminidase
assay and the mixtures were incubated at 37 °C for 6 h. The
reaction was terminated by addition of 100 μl 0.1 M Na2CO3 (pH
10.0). The absorbance of the colored product was assessed at
405 nm and the values were expressed as the percentage of total
β-D-glucosaminidase activity from rat mast cell suspensions in the
presence of 0.1% (v/v) Triton X-100 (used as 100% control).
Histamine release assay
Mast cells were obtained by peritoneal washing of adult Wistar
rats with Tyrode's solution. Ten microliter samples were added to
90 μl mast cells suspensions and incubated at 37 °C for 15 min. The
reaction was terminated by adding the ice-cold Tyrode's solution
(2.9 ml). The cell suspensions were then centrifuged and both the
supernatants and cell pellets were tested for histamine concentration
as described[24]. Histamine-releasing activity was expressed as the
percentage of the total cellular content and the values were corrected
for spontaneous release without 5% exceeding in the absence of
peptides.
Synthetic peptides
All peptides used for bioassays were synthesized by GL Biochem
(Shanghai) Ltd. (Shanghai, China) and analyzed by HPLC and mass
spectrometry to conﬁrmed purity higher than 95%. All peptides were
solved in water.Acknowledgments
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Supplementary data associated with this article can be found, in
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